Manresa, Spain

Jose-Luis Diaz-Fernández


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Jose-Luis Diaz-Fernández

Introduction: Jose-Luis Diaz-Fernández, based in Manresa, Spain, is a distinguished inventor whose work has contributed significantly to the field of pharmaceuticals. With his innovative approach, he has developed a unique patent that highlights his expertise and dedication to addressing pain management through new chemical compounds.

Latest Patents: Jose-Luis holds a significant patent titled "Arylamide derivatives having multimodal activity against pain." This invention focuses on arylamide derivatives designed to exhibit dual pharmacological activity towards the α2δ subunit of the voltage-gated calcium channel and the μ-opioid receptor. The patent outlines processes for preparing these novel compounds, the pharmaceutical compositions containing them, and their therapeutic applications, particularly targeting pain treatment.

Career Highlights: Currently, Jose-Luis is making strides in his role at Esteve Pharmaceuticals, S.A., a company known for its commitment to developing innovative therapeutic solutions. His work demonstrates a profound understanding of pharmacology, as well as a dedication to improving patient outcomes through scientific research.

Collaborations: Throughout his career, Jose-Luis has collaborated with esteemed colleagues such as Pilar Goya and Antoni Torrens-Jover. These partnerships reflect his ability to work effectively within a team, bringing together diverse expertise to foster innovation in pharmaceutical research.

Conclusion: Jose-Luis Diaz-Fernández stands out as a notable inventor in the pharmaceutical industry, making significant contributions through his patented work and collaborations. His innovative approach to pain management is indicative of the ongoing efforts to enhance therapeutic strategies and improve the quality of life for patients suffering from pain. Through his continued work with Esteve Pharmaceuticals, he is poised to influence the future of pain treatment and pharmaceutical development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…